Pila Pharma AB (OSTO:PILA) FCF Margin % : -206.28% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Pila Pharma AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pila Pharma AB's Free Cash Flow for the three months ended in Dec. 2023 was kr-0.76 Mil. Pila Pharma AB's Revenue for the three months ended in Dec. 2023 was kr0.37 Mil. Therefore, Pila Pharma AB's FCF Margin % for the quarter that ended in Dec. 2023 was -206.28%.

As of today, Pila Pharma AB's current FCF Yield % is -4.76%.

The historical rank and industry rank for Pila Pharma AB's FCF Margin % or its related term are showing as below:

OSTO:PILA' s FCF Margin % Range Over the Past 10 Years
Min: -1456.07 Med: -892.84 Max: -331.78
Current: -331.78

During the past 6 years, the highest FCF Margin % of Pila Pharma AB was -331.78%. The lowest was -1456.07%. And the median was -892.84%.

OSTO:PILA's FCF Margin % is ranked worse than
61.73% of 1040 companies
in the Biotechnology industry
Industry Median: -137.43 vs OSTO:PILA: -331.78

Pila Pharma AB FCF Margin % Historical Data

The historical data trend for Pila Pharma AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pila Pharma AB FCF Margin % Chart

Pila Pharma AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,456.07

-1,302.36

-483.31

-331.78

Pila Pharma AB Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial											-442.37	-209.17	-544.52	-	-206.28

Competitive Comparison of Pila Pharma AB's FCF Margin %

For the Biotechnology subindustry, Pila Pharma AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pila Pharma AB's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pila Pharma AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pila Pharma AB's FCF Margin % falls into.

Pila Pharma AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pila Pharma AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-4.854	/	1.463
	=	-331.78 %

Pila Pharma AB's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.755	/	0.366
	=	-206.28 %

Pila Pharma AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Pila Pharma AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pila Pharma AB (OSTO:PILA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pila Pharma AB (OSTO:PILA) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

5KC:Germany

Address

Vastergatan 1, Malmo, SWE, 211 21

Website

https://www.pilapharma.com

Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.

Pila Pharma AB (OSTO:PILA) Headlines

No Headlines